Event

A PSI Pre-Conference Training Course

A PSI Pre-Conference Training Course on Subgroup Analysis

Presented by
Aaron Dane, Armin Koch, 
Ilya Lipkovich & Gerd Rosenkranz

It is common to conduct subgroup analyses in clinical trials at all phases of drug development. Consistency of treatment effect across subgroups indicates that the conclusions made regarding treatment benefit are applicable across various baseline characteristics and associated subpopulations, whilst substantial heterogeneity in treatment effect may suggest clinically relevant differential treatment effects across relevant subpopulations. At the extreme, the presence of substantial heterogeneity may imply that the conclusion of beneficial treatment effect is only relevant for a subset of the population. Interpretation of subgroup analyses is challenging as subgroup findings can be due to chance. This is particularly likely when a large number of subgroup analyses are undertaken. Further, clinical trials are generally not powered for detecting heterogeneity, so statistical tests may also miss important interactions due to low power.

EMA issued draft guidance on approaches to subgroup analysis and convened a workshop to discuss this guidance in 2014, with further work ongoing within PSI to explore approaches to analysis that may be acceptable in regulatory submissions, with the aim of having further interactions with regulatory agencies regarding their use.

This course will address the importance of pre-specification, how this can help inform interpretation of apparent subgroup findings, will outline the key concepts from the EMA draft guidance and will introduce approaches to subgroup analysis which account for some the issues described. The course will consist of lectures. There will not be any computer exercises.

The following key topics will Be Covered   
The documents from US and European regulators
 The used of bias-adjusted analyses to account for the over-selection inherent when conducting a number of subgroup analyses
The role of subgroup pre-specification and how this can inform the analysis and interpretation process
 Presentation of results from Bayesian analyses looking to borrow information across subgroups, or to incorporate prior data and belief into the analysis.
The use of graphical methods to understand subgroup effects in the context of the number of analyses performed
  


Course runs from:       13:00 – 17:00 on the first day (Sunday) of the conference

PLEASE CLICK HERE TO SEE THE FLYER

Registration
This Course is now fully booked.

Costs  
 240 Euros 
 Early Bird rate – up to 29th February 2016
 285 Euros 
 Standard rate – 1st March 2016 onwards

Includes refreshments during course only (no accommodation or dinner)

PSI aims to be fully inclusive and endeavours to accommodate delegates with disabilities wherever possible.  Please help us to help you by letting us know if you require additional facilities or have any special requirements.  Please contact us on +44 (0) 1730 715 235 or at PSI@mci-group.com for further information.

Contact:   Georgie Leonard  Tel:  +44 (0) 1730 715 235   Email: PSI@mci-group.com

Upcoming Events

PSI Training Course: Introduction to Machine Learning

This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.

Joint PSI/EFSPI Vaccine SIG Webinar: Statistical and Mechanistic Models for Correlates of Protection

This webinar will explore two different approaches to Correlates of Protection in vaccine development.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Webinar: Drug Development in Women's Health

The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.

PSI Webinar: Surrogacy

This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.

Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies

Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.

Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium

We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.

PSI Career Young Virtual Event (Q2 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q3 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Introduction to Industry Training (ITIT) Course - 2024/2025

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q4 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Latest Jobs

Statistician, Data Science

We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.